Landos Biopharma's Series A Round

Landos Biopharma raised a round of funding on September 21, 2017. Investors include Perceptive Advisors.

Landos Biopharma is developing a pharmaceutical pipeline for autoimmune diseases toward commercialization. Landos will focus its development efforts in a novel target pathway called Lanthionine Synthe…

Articles about Landos Biopharma's Series A Round: